Nano cap OpGen (NASDAQ:OPGN) rallies 53% premarket on robust volume in reaction to its announcement that subsidiary Curetis GmbH has received CE Mark certification for its SARS-CoV-2 molecular test w… [+261 chars]
OpGen up 53% on launch of COVID-19 test in Europe – Seeking Alpha